CTX-M-14 β-lactamase-producing Citrobacter freundii isolated in Venezuela

Annals of Clinical Microbiology and Antimicrobials

Volumn 10, Issue , 2011, Pages

  Millán, Beatriz ^a   Ghiglione, Bárbara ^b   Díaz, Tulia ^a   Gutkind, Gabriel ^b   Araque, María ^a  

^a UNIVERSIDAD DE LOS ANDES   (Venezuela)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Citrobacter freundii; CTX M 14; Extended spectrum lactamases; FrepB replicon; Plasmid

Indexed keywords

AMIKACIN; AZTREONAM; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE CTX M; BETA LACTAMASE CTX M 14; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; CLAVULANIC ACID; GENTAMICIN; IMIPENEM; MEROPENEM; TOBRAMYCIN; UNCLASSIFIED DRUG; BETA LACTAMASE; BETA-LACTAMASE CTX-M-14;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATION; CASE REPORT; CITROBACTER FREUNDII; CYSTOCELE; ENZYME ACTIVITY; FEMALE; GENE SEQUENCE; HUMAN; NONHUMAN; PLASMID; POLYMERASE CHAIN REACTION; RECURRENT INFECTION; REPLICON; URINARY TRACT INFECTION; VENEZUELA; BACTERIUM CONJUGATION; ENTEROBACTERIACEAE INFECTION; ENZYMOLOGY; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; MIDDLE AGED;

BETA-LACTAMASES; CITROBACTER FREUNDII; CONJUGATION, GENETIC; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HUMANS; MIDDLE AGED; PLASMIDS; VENEZUELA;

EID: 79957635313     PISSN: None     EISSN: 14760711     Source Type: Journal    
DOI: 10.1186/1476-0711-10-22     Document Type: Article

References (26)

1. Pitout JDD. Infections with extended-spectrum β-lactamase-producing Enterobacteriaceae. Changing epidemiology and drug treatment choices. Drugs 2010, 70(3):313-333. 10.2165/11533040-000000000-00000, 20166768.
2. Falagas ME, Karageorgopoulos DE. Extended-spectrum β-lactamase-producing organisms. J Hosp Infect 2009, 73:345-354. 10.1016/j.jhin.2009.02.021, 19596491.
3. Rodríguez-Baño J, Pascual A. Clinical significance of extended-spectrum β-lactamases. Expert Rev Anti Infect Ther 2008, 6(5):671-683. 10.1586/14787210.6.5.671, 18847405.
4. Rossi A Galas M, Corso A, Radice M, Rivas M, Caffer M, Binztein N, Gutkind G. Unussual multiresistant Vibrio cholerae O1 var. El Tor in Argentina. Lancet 1993, 342:1172-1173.
5. Lavigne JP, Defez C, Bouziges N, Mahamat A, Sotto A. Clinical and molecular epidemiology of multidrug-resistant Citrobacter spp. infections in a French university hospital. Eur J Clin Microbiol Infect Dis 2007, 26:439-441. 10.1007/s10096-007-0315-3, 17516102.
6. Munday CJ, Whitehead GM, Todd NJ, Campbell M, Hawkey PM. Predominance and genetic diversity of community- and hospital acquired CTX-M extended-spectrum β-lactamases in York, UK. J Antimicrobial Chemother 2004, 54:628-633.
7. Abdalhamid B, Pitout JDD, Moland ES, Hanson ND. Community-onset disease caused by Citrobacter freundii producing a novel CTX-M β-lactamase, CTX-M-30, in Canada. Antimicrob Agents Chemother 2004, 48:4435-4437. 10.1128/AAC.48.11.4435-4437.2004, 525418, 15504875.
8. Kim J, Lim YM. Prevalence of derepressed AmpC mutants and extended-spectrum β-lactamase producers among clinical isolates of Citrobacter freundii, Enterobacter spp., and Serratia marcescens in Korea: dissemination of CTX-M-3, TEM-52, and SHV-12. J Clin Microbiol 2005, 43:2452-2455. 10.1128/JCM.43.5.2452-2455.2005, 1153749, 15872281.
9. Muta T, Tsuruta N, Seki Y, Ota R, Suzuki S, Shibata N, Kato K, Eto T, Gondo H, Arakawa Y. A nosocomial outbreak due to novel CTX-M-2-producing strains of Citrobacter koseri in a hematological ward. Jpn J Infect Dis 2006, 59:69-71.
10. Zhang R, Yang L, Cai JC, Zhou HW, Chen GX. High level carbapenem resistance in a Citrobacter freundii clinical isolate is due to a combination of KPC-2 production and porin expression. J Med Microbiol 2008, 57:332-337. 10.1099/jmm.0.47576-0, 18287296.
11. Shahid M. Citrobacter spp. simultaneously harboring blaCTX-M, blaTEM, blaSHV, blaampC, and insertion sequences IS26 and orf513: an evolutionary phenomenon of recent concern for antibiotic resistance. J Clin Microbiol 2010, 48:1833-1838. 10.1128/JCM.01467-09, 2863875, 20220171.
12. Clinical and Laboratory Standards Institute (CLSI) Performance standards for antimicrobial susceptibility testing, 21th informational supplement. CLSI Document M100-S20. Wayne, PA. 2011, Clinical and Laboratory Standards Institute (CLSI).
13. Labia R, Barthélémy M. Beta-lactamase enzymogram": an agar adaptation of the iodometric method. Ann Microbiol 1979, 30B(3):295-304.
14. Rossi A, Lopardo H, Picandet AM, Mariño M, Galds M, Radice M, Gutkind G. Non-Typhoid Salmonella spp. resistant to cefotaxime. J Antimicrobial Chemother 1995, 36(4):697-702.
15. Birnboim HC, Doly J. A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acid Res 1979, 7:1513-1523. 10.1093/nar/7.6.1513, 342324, 388356.
16. Carattoli A, Bertini A, Villa L, Falbo V, Hopkins KL, Threlfall EJ. Identification of plasmids by PCR-based replicon typing. J Microbiol Methods 2005, 63:219-228. 10.1016/j.mimet.2005.03.018, 15935499.
17. Minarini LAR, Poirel L, Trevisani NAC, Darini ALC, Nordmann P. Predominance of CTX-M-type extended-spectrum β-lactamase genes among enterobacterial isolates from outpatients in Brazil. Diagn Microbiol Infect Dis 2009, 65:202-206. 10.1016/j.diagmicrobio.2009.05.021, 19748435.
18. Raz R, Gennesin Y, Wasser J, Stoler Z, Rosenfeld S, Rottensterich E, Stamm WE. Recurrent urinary tract infections in postmenopausal women. Clin Infect Dis 2000, 30:152-156. 10.1086/313596, 10619744.
19. Carattoli A. Resistance plasmid families in Enterobacteriaceae. Antimicrob Agents Chemother 2009, 53:2227-2238. 10.1128/AAC.01707-08, 2687249, 19307361.
20. Araque M, Nieves B, Lauretti L, Rossolini GM. Molecular basis of extended-spectrum β-lactamase production in nosocomial isolates of Klebsiella pneumoniae from Mérida, Venezuela. Int J Antimicrob Agents 2000, 15:37-42. 10.1016/S0924-8579(99)00168-5, 10856675.
21. Araque M, Rivera I. Simultaneous presence of blaTEM and blaSHV genes on a large conjugative plasmid carried by extended-spectrum β-lactamase-producing Klebsiella pneumoniae. Am J Med Sci 2004, 327:118-122. 10.1097/00000441-200403000-00002, 15090749.
22. Guzmán M, Alonso G. Caracterización de β-lactamasas de espectro extendido (BLEE) en cepas nosocomiales de K. pneumoniae. Sucre-Venezuela. Inves Clin 2009, 50:419-431.
23. Torres L, Gagliotta V, Torres O, Benitez M, Dominguez M, Pedroza R. β-lactamasa de espectro expandido en enterobacterias aisladas en centros de salud de Caracas. Rev Soc Venez Microbiol 2006, 26:80-88.
24. Marcadé G, Deschamps C, Boyd A, Gautier V, Picard B, Branger C, Denamur E, Arlet G. Replicon typing of plasmids in Escherichia coli producing extended-spectrum β-lactamases. J Antimicrob Chemother 2009, 63:67-71.
25. Valverde A, Cantón R, Garcillán-Barcia MP, Novais A, Galán JC, Alvarado A, de la Cruz F, Baquero F, Coque TM. Spread of blaCTX-M-14 is driven mainly by IncK plasmids disseminated among Escherichia coli phylogroups A, B1, and D in Spain. Antimicrob Agents Chemother 2009, 53:5204-5212. 10.1128/AAC.01706-08, 2786348, 19786598.
26. Pitout JDD, Gregson DB, Church DL, Elsayed S, Laupland KV. Community-wide outbreaks of clonally related CTX-M-14 β-lacatmase-producing Escherichia coli strains in the Calgary health region. J Clin Microb 2005, 43:2844-2849.